Novo Nordisk Helps Lift European Stocks Despite Yen’s 40-Year Low and $80 Oil
NVO•European stocks ended higher as drugmakers Novo Nordisk and AstraZeneca offset a 0.14% slide in the MSCI All-World index after U.S.-Iran peace talks collapsed. The yen tumbled to its weakest since 1986, heightening intervention risk, while Brent crude climbed to $80 a barrel on renewed Middle East tensions.
1. Global Market Reaction
Global shares retreated after U.S.-Iran peace talks collapsed, sending the MSCI All-World index down 0.14%. Oil prices rose to $80 a barrel on concerns that renewed hostilities could disrupt Strait of Hormuz shipping.
2. European Stocks Supported by Novo Nordisk
European equities bucked the global downturn, ending positive as drugmakers including Novo Nordisk and AstraZeneca led gains. Shares of Novo Nordisk were among the top performers, helping the STOXX Europe 600 close in positive territory.
3. Currency and Oil Movements
The Japanese yen slid to its weakest level since late 1986, heightening intervention risk as officials signal readiness to act. Brent crude climbed to $80 a barrel amid waning confidence in a lasting ceasefire and resumed Middle East tensions.
